CRABP2 and esophageal cancer: In summary, by integrating public databases, it is found that CRABP2 is significantly low in EC and may participate in the development of esophageal cancer through related metabolism, which has a certain reference value for clinical treatment and judging the prognosis of esophageal cancer.